Arena Pharmaceuticals(ARNA) was the second-most damaging stock for drug and biotech investors in the just-closed quarter, losing 56% after a U.S. advisory panel voted down the company's weight-loss drug lorcaserin. http://www.thestreet.com/_yahoo/story/10876934/1/best-and-worst-drug-stocks-in-q3.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA